CGEM
Cullinan Oncology (CGEM)
$
53About Cullinan Oncology (CGEM)
Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Details
Daily high
$9.93
Daily low
$9.47
Price at open
$9.58
52 Week High
$30.19
52 Week Low
$9.47
Market cap
554.9M
Dividend yield
0.00%
Volume
280,816
Avg. volume
430,527
P/E ratio
-3.31
Cullinan Oncology News
Details
Daily high
$9.93
Daily low
$9.47
Price at open
$9.58
52 Week High
$30.19
52 Week Low
$9.47
Market cap
554.9M
Dividend yield
0.00%
Volume
280,816
Avg. volume
430,527
P/E ratio
-3.31